Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905729-25-000184
Filing Date
2025-11-13
Accepted
2025-11-13 08:05:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13573
2 JOINT FILING AGREEMENT ccp13gneogenex991.htm EX-99.1 18999
  Complete submission text file 0000905729-25-000184.txt   34349
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Subject) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-40503 | Film No.: 251475516
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 303 E. THIRD STREET SUITE 110 ROCHESTER MI 48307
Business Address 303 E. THIRD STREET SUITE 110 ROCHESTER MI 48307 248-723-8000
Clarkston Capital Partners, LLC (Filed by) CIK: 0001562855 (see all company filings)

EIN.: 830473650 | State of Incorp.: MI | Fiscal Year End: 1231
Type: SCHEDULE 13G/A